Market Size of North America Ablation Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 8.50 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
North America Ablation Technologies Market Analysis
The North America Ablation Devices Market is expected to register a CAGR of nearly 8.5 % during the forecast period. Rising incidences of diseases such as cancer and cardiac ailments are expected to boost the demand for ablation procedures. The technological advancements to design high-end products and growing demand for treatment procedures, which are minimally invasive are also expected to boost the ablation technologies market.
Furthermore, the rising number of the ageing population having a higher risk of target diseases is another vital factor driving the demand for ablation procedures.
According to the Canadian Cancer Statistics 2019 report, it is estimated that nearly 1 in 2 Canadians will be diagnosed with cancer in their lifetime. An estimated 220,400 new cases of cancer are diagnosed in Canada in 2019. The number of cases in males (113,000) was expected to be slightly higher than in females (107,400).
Therefore, the rising prevalence of cancer and other chronic diseases is expected to show significant growth over the forecast period. However, stringent regulatory framework leading to an increase in the gestation period for product launches is also a market challenge which is hindering the market growth.
North America Ablation Technologies Industry Segmentation
As per the scope of the report, ablation generally refers to the removal of a part of biological tissue, usually by surgery. Ablation devices offer a minimally invasive alternative to traditional surgical treatment of liver, prostate, kidney and lung cancers. The North America Ablation Devices market is segmented by technology, application, end-User, and geography.
| By Device Technology | |
| Radiofrequency Devices | |
| Laser/Light Ablation | |
| Ultrasound Devices | |
| Cryoablation Devices | |
| Other Devices |
| By Application | |
| Cancer Treatment | |
| Cardiovascular Disease Treatment | |
| Ophthalmologic Treatment | |
| Gynecological Treatment | |
| Urological Treatment | |
| Cosmetic Surgery | |
| Other Applications |
| By End-Users | |
| Hospitals | |
| Ambulatory Surgical Centers | |
| Other End-Users |
| Geography | |||||
|
North America Ablation Devices Market Size Summary
The North America Ablation Devices Market is poised for significant growth, driven by the increasing prevalence of diseases such as cancer and cardiac conditions. The demand for minimally invasive treatment procedures is on the rise, supported by technological advancements in the development of high-end ablation products. The ageing population, which is more susceptible to these diseases, further fuels the demand for ablation procedures. Despite the challenges posed by a stringent regulatory framework that extends the product launch timeline, the market is expected to expand due to the rising incidence of chronic diseases and the need for effective treatment solutions.
North America's robust healthcare infrastructure and substantial investment in cancer research and development are key factors contributing to the market's growth. The region's healthcare system is better equipped compared to other global regions, and this advantage is expected to drive the ablation devices market forward. Major players such as Abbott, AngioDynamics, Inc., AtriCure, Inc., and Boston Scientific Corporation dominate the market, holding significant shares. The competitive landscape is moderately concentrated, with these companies leading the charge in innovation and market presence, ensuring the market's continued expansion over the forecast period.
North America Ablation Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rise in the Prevalence of Chronic Diseases
-
1.2.2 Emergence of Next-generation Ablation Products and Technology
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Device and Stringent Regulations
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Device Technology
-
2.1.1 Radiofrequency Devices
-
2.1.2 Laser/Light Ablation
-
2.1.3 Ultrasound Devices
-
2.1.4 Cryoablation Devices
-
2.1.5 Other Devices
-
-
2.2 By Application
-
2.2.1 Cancer Treatment
-
2.2.2 Cardiovascular Disease Treatment
-
2.2.3 Ophthalmologic Treatment
-
2.2.4 Gynecological Treatment
-
2.2.5 Urological Treatment
-
2.2.6 Cosmetic Surgery
-
2.2.7 Other Applications
-
-
2.3 By End-Users
-
2.3.1 Hospitals
-
2.3.2 Ambulatory Surgical Centers
-
2.3.3 Other End-Users
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
-
North America Ablation Devices Market Size FAQs
What is the current North America Ablation Devices Market size?
The North America Ablation Devices Market is projected to register a CAGR of 8.5% during the forecast period (2024-2029)
Who are the key players in North America Ablation Devices Market?
Abbott Laboratories, Boston Scientific Corporation, Johnson and Johnson (Biosense Webster, Inc), Medtronic PLC and AngioDynamics, Inc are the major companies operating in the North America Ablation Devices Market.
